This trial looked at an immunotherapy drug called magrolimab alone or with azacitidine for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).
This is a trial of lenzilumab for people with high risk acute graft versus host disease.
This trial is comparing standard treatment with 2 newer combinations of treatment to prevent GvHD.
This study is looking at blinatumomab for people with acute myeloid leukaemia (AML).
This trial is for adults with B-cell acute lymphoblastic leukaemia that has come back or got worse (relapsed) or treatment has stopped working (refractory).
This trial is comparing venetoclax and azacitidine with azacitidine for acute myeloid leukaemia (AML).
This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.
This study is looking at treatment for acute lymphoblastic leukaemia (ALL). It is for children and young adults who have just been diagnosed.
This trial is for people with blood cancer that has come back or is getting worse despite treatment.
This trial is looking at new combinations of chemotherapy before a stem cell transplant to improve treatment for people with AML and MDS.
